TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Rechon Life Science AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
362,156
|
326,389
|
259,442 |
| Financial expenses |
2,561
|
2,102
|
866 |
| Earnings before taxes |
38,426
|
37,902
|
40,264 |
| EBITDA |
53,165
|
52,863
|
52,013 |
| Total assets |
315,903
|
244,707
|
218,478 |
| Current assets |
173,714
|
137,686
|
112,442 |
| Current liabilities |
93,320
|
67,757
|
53,338 |
| Equity capital |
162,005
|
136,324
|
113,378 |
| - share capital |
17,887
|
18,499
|
18,404 |
| Employees (average) |
286
|
249
|
212 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
51.3%
|
55.7%
|
51.9% |
| Turnover per employee |
1,266
|
1,311
|
1,224 |
| Profit as a percentage of turnover |
10.6%
|
11.6%
|
15.5% |
| Return on assets (ROA) |
13.0%
|
16.3%
|
18.8% |
| Current ratio |
186.1%
|
203.2%
|
210.8% |
| Return on equity (ROE) |
23.7%
|
27.8%
|
35.5% |
| Change turnover |
46,563
|
65,611
|
55,196 |
| Change turnover % |
15%
|
25%
|
27% |
| Chg. No. of employees |
37
|
37
|
28 |
| Chg. No. of employees % |
15%
|
17%
|
15% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.